Results 111 to 120 of about 19,736 (150)

A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanoma. [PDF]

Mol Ther Oncol
Stauber D, Sosnick L, Ma Y, Pimcharoen S, Lawanprasert A, Murthy N, Myung D, Qi LS.   +7 more
europepmc   +1 more source

Prognostic value of BAP1 expression in uveal melanoma: a comparative study with histopathological factors in a large Spanish cohort. [PDF]

Front Oncol
Valencia Nieto P, García Álvarez C, García Lagarto ME, Muñoz Moreno MF, Diezhandino García P, Saornil Álvarez MA.   +5 more
europepmc   +1 more source

Nine familial exterminations: Cas13d eliminates uveal melanoma cells through collateral RNA degradation. [PDF]

Mol Ther Oncol
Zheng D, Gu B.
europepmc   +1 more source

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence. [PDF]

Front Pharmacol
Gu D, Feng Y, Li H.
europepmc   +1 more source

Identification of targetable epigenetic vulnerabilities for uveal melanoma. [PDF]

Cell Death Dis
Yenisehirli G, Borges S, Braun SS, Zuniga AN, Quintana GI, Kutsnetsoff JN, Volonterio RL, Rodriguez S, Adis EV, Lopez S, Dollar JJ, Stathias V, Volmar CH, Karaca E, Brothers SP, Bilbao D, Harbour JW, Correa ZM, Kurtenbach S.   +18 more
europepmc   +1 more source

Hepatic metastasis surveillance in uveal melanoma: a retrospective cohort study from a UK tertiary centre (2006-2022). [PDF]

Br J Cancer
Rea B, Salehi M, Maiter A, Ochieng L, Lanham S, Kang J, Sinha S, Hawthorn J, Gill A, Johns C, Campbell MJ, Harley U, Quhill H, Salvi S.   +13 more
europepmc   +1 more source

Clinical Applications of Artificial Intelligence in Uveal Melanoma. [PDF]

Anticancer Res
Chadwick WF, Ganesh S, Dadzie AK, Ebrahimi B, Rahimi M, Son T, Alahmadi R, Yao X, Heiferman MJ.   +8 more
europepmc   +1 more source

Effect of Social Determinants of Health and Geography on Uveal Melanoma. [PDF]

Clin Ophthalmol
Sureshkumar H, Kolla S, Erukulla R, Ma W, Alahmadi R, Sun J, Heiferman MJ.   +6 more
europepmc   +1 more source

Early genetic evolution of driver mutations in uveal melanoma. [PDF]

Nat Commun
Dollar JJ, Decatur CL, Weis E, Schefler AC, Materin MA, Fuller TS, Skalet AH, Reichstein DA, Kim IK, Piggott KD, Demirci H, Aaberg TA, Mruthyunjaya P, Williams BK, Shildkrot E, Oliver SCN, Char DH, Capone A, Mason JO, Walter SD, Altaweel MM, Wells JR, Gombos DS, Duker JS, Hovland PG, Tsai T, Javid C, Durante MA, Covington KR, Zhang S, Correa ZM, Harbour JW.   +31 more
europepmc   +1 more source